One Stop Shop for All Your Market Research Reports

Europe Drugs for Schistosomiasis Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty. Scope of the Report: This report focuses on the Drugs for Schistosomiasis in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Shin Poong Merck Bayer EIPICO Chandra Bhagat Pharma Taj Pharmaceuticals Market Segment by Countries, covering Germany UK France Russia Italy Market Segment by Type, covers Praziquantel Oxamniquine Other Market Segment by Applications, can be divided into S. haematobium S. mansoni S. japonicum S. mekongi S. intercalatum There are 17 Chapters to deeply display the Europe Drugs for Schistosomiasis market. Chapter 1, to describe Drugs for Schistosomiasis Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Drugs for Schistosomiasis, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Drugs for Schistosomiasis, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications; Chapter 12, Drugs for Schistosomiasis market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe Drugs for Schistosomiasis sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe Drugs for Schistosomiasis Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Drugs for Schistosomiasis Introduction 1.2 Market Analysis by Type 1.2.1 Praziquantel 1.2.2 Oxamniquine 1.2.3 Other 1.3 Market Analysis by Applications 1.3.1 S. haematobium 1.3.2 S. mansoni 1.3.3 S. japonicum 1.3.4 S. mekongi 1.3.5 S. intercalatum 1.4 Market Analysis
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 4480
Corporate User US $8960
About this Report
Report ID 209621
Category
  • Healthcare
Published on 27-Jul
Number of Pages 120
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(47)